Agios Pharmaceuticals, Inc.
DE ˙ DB ˙ US00847X1046
23,40 € ↑0,80 (3,54%)
2026-06-04
DEL PRIS
SecurityDE:8AP / Agios Pharmaceuticals, Inc.
InstitutionMillennium Management Llc
ManagerIsrael Englander
Latest Disclosed Ownership32,144 shares
Latest Disclosed Value $ 1,087,432
Millennium Management Llc ownership in 8AP / Agios Pharmaceuticals, Inc.

On May 15, 2026 - Millennium Management Llc filed a 13F-HR form disclosing ownership of 32,144 shares of Agios Pharmaceuticals, Inc. (DE:8AP) valued at $829,315 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 398,267 shares of Agios Pharmaceuticals, Inc.. This represents a change in shares of -91.93% during the quarter. The current value of the position is $752,170 USD.

Millennium Management Llc has a history of taking positions in derivatives of the underlying security (8AP) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:8AP / Agios Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 32,144 -366,123 -91.93 1,087 -89.97 0.0005
2026-02-17 2025-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 398,267 393,218 7,788.04 10,841 5,266.34 0.0046
2025-11-14 2025-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 5,049 -295,154 -98.32 203 -97.98 0.0001
2025-08-14 2025-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 300,203 247,130 465.64 9,985 542.06 0.0048
2025-05-15 2025-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 53,073 30,877 139.11 1,555 113.31 0.0008
2025-02-14 2024-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 22,196 -55,734 -71.52 729 -78.94 0.0004
2024-11-14 2024-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 77,930 46,843 150.68 3,462 158.36 0.0016
2024-08-14 2024-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 31,087 -16,514 -34.69 1,340 -3.67 0.0006
2024-05-15 2024-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 47,601 3,242 7.31 1,392 40.93 0.0006
2024-02-14 2023-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 44,359 32,007 259.12 988 223.61 0.0004
2023-11-14 2023-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 12,352 -161,653 -92.90 306 -93.81 0.0002
2023-08-14 2023-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 174,005 112,316 182.07 4,928 247.71 0.0024
2023-05-15 2023-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 61,689 61,689 1,417 0.0008
2023-02-14 2022-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 0 -58,421 -100.00 0 -100.00
2022-11-14 2022-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 58,421 -65,409 -52.82 1,652 -39.82 0.0010
2022-08-15 2022-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 123,830 82,995 203.24 2,745 130.87 0.0017
2022-05-16 2022-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 40,835 -49,404 -54.75 1,189 -59.91 0.0006
2022-02-14 2021-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 90,239 76,651 564.11 2,966 373.05 0.0015
2021-11-15 2021-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 13,588 13,588 627 0.0004
2021-08-16 2021-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 0 -233,815 -100.00 0 -100.00
2021-05-17 2021-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 233,815 -70,450 -23.15 12,074 -8.42 0.0086
2021-02-16 2020-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 304,265 226,363 290.57 13,184 383.46 0.0095
2020-11-16 2020-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 77,902 -52,850 -40.42 2,727 -61.00 0.0034
2020-08-14 2020-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 130,752 -147,176 -52.95 6,993 -29.08 0.0096
2020-05-14 2020-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 277,928 -68,275 -19.72 9,861 -40.35 0.0222
2020-02-14 2019-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 346,203 133,095 62.45 16,531 139.44 0.0207
2019-11-14 2019-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 213,108 169,566 389.43 6,904 217.86 0.0109
2019-08-15 2019-06-30 13F/A-1 AGIOS PHARMACEUTICALS COM 00847X104 43,542 43,542 2,172 0.0033
2019-05-14 2019-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 0 -215,902 -100.00 0 -100.00
2019-02-15 2018-12-31 13F/A-1 AGIOS PHARMACEUTICALS COM 00847X104 215,902 160,493 289.65 9,955 132.97 0.0155
2019-02-14 2018-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 215,902 9,955
2018-11-14 2018-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 55,409 55,409 4,273 0.0052
2017-08-14 2017-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 0 -37,506 -100.00 0 -100.00
2017-05-15 2017-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 37,506 -204,804 -84.52 2,190 -78.34 0.0040
2017-02-14 2016-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 242,310 155,070 177.75 10,112 119.44 0.0212
2016-11-14 2016-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 87,240 -14,661 -14.39 4,608 7.94 0.0077
2016-08-15 2016-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 101,901 -764,038 -88.23 4,269 -87.86 0.0098
2016-05-16 2016-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 865,939 824,485 1,988.92 35,157 1,206.47 0.0879
2016-02-16 2015-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 41,454 41,454 0.00 2,691 0.0057
2015-08-14 2015-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 0 -69,363 -100.00 0 -100.00
2015-05-15 2015-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 69,363 69,363 0.00 6,541 0.0122
2015-02-17 2014-12-31 13F AGIOS PHARMACEUTICALS COM 00847X104 0 -21,600 -100.00 0 -100.00
2014-11-14 2014-09-30 13F AGIOS PHARMACEUTICALS COM 00847X104 21,600 21,600 0.00 1,325 0.0034
2014-08-14 2014-06-30 13F AGIOS PHARMACEUTICALS COM 00847X104 0 -34,000 -100.00 0 -100.00
2014-05-15 2014-03-31 13F AGIOS PHARMACEUTICALS COM 00847X104 34,000 34,000 1,331 0.0039
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-05-15 2023-03-31 13F AGIOS PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-14 2022-12-31 13F AGIOS PHARMACEUTICALS COM Call 15,000 421 n/a n/a n/a
2021-08-16 2021-06-30 13F AGIOS PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-17 2021-03-31 13F AGIOS PHARMACEUTICALS COM Call 15,000 775 n/a n/a n/a
2020-11-16 2020-09-30 13F AGIOS PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-14 2020-06-30 13F AGIOS PHARMACEUTICALS COM Call 85,000 4,546 n/a n/a n/a
2020-02-14 2019-12-31 13F AGIOS PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-11-14 2019-09-30 13F AGIOS PHARMACEUTICALS COM Call 75,000 -25.00 2,430 -51.28 n/a n/a n/a
2019-08-15 2019-06-30 13F/A AGIOS PHARMACEUTICALS COM Call 100,000 4,988 n/a n/a n/a
2019-08-14 2019-06-30 13F NUVASIVE COM Call 30,000 1,756 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F AGIOS PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-17 2025-12-31 13F AGIOS PHARMACEUTICALS COM Put 20,000 544 n/a n/a n/a
2019-11-14 2019-09-30 13F WISDOMTREE TR INDIA ERNGS FD Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-14 2019-06-30 13F WISDOMTREE TR INDIA ERNGS FD Put 245,000 390.00 6,385 205.94 n/a n/a n/a
2017-02-14 2016-12-31 13F AGIOS PHARMACEUTICALS COM Put 50,000 2,087 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.